September, 02 2026 Wednesday 11:33 Hrs
Last update 11-9-2025
  • SENSEX :   76,282.72

  • Top commodity trading and broking companies in India-661.56( -0.86%) 02-Sep-2026

IPO Synopsis

Symbiotec Pharmalab Ltd
Initial public offering of 17,786,442 equity shares of face value of Rs. 2 each ("Equity Shares") of the company for cash at a price of Rs. 988.00 per equity share ( Including a Share Premium of Rs. 986.00 Per Equity Share) ("Offer Price") aggregating Rs. 1757.00 Crores ("Offer"). The offer comprised a fresh issue of 1,521,261 equity shares of face value of Rs. 2 each aggregating Rs. 150.00 Crores by the company ("Fresh Issue") and an offer for sale of 16,265,181 equity shares of face value of Rs. 2 each ("Offered Shares") aggregating Rs.1607.00 Crores, comprising of 1,457,489 equity shares of face value of Rs. 2 each aggregating Rs. 144.00 Crores by Satwani Holdings LLP (the "Promoter Selling Shareholder"), 10,000,000 equity shares of face value of Rs. 2 each aggregating Rs.988.00 Crores by Rosewood Investments and 4,807,692 equity shares of face value of Rs. 2 each aggregating Rs. 475.00 Crores by India Business Excellence fund - III (the "Investor Selling Shareholders", and together with the promoter selling shareholder, the "Selling Shareholders" and such offer for sale of equity shares by the selling shareholders, the "Offer For Sale"). The offer will constituted 27.68% of the post-offer paid up equity share capital of the company. The offer includes a reservation of 33,407 equity shares of face value of Rs. 2 each aggregating Rs. 3.00 Crores ( Constituting 5% of the post offer paid-up equity share capital of the company), for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute 27.68% and 27.63%, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, may offer a discount of 9.11% (equivalent to Rs.90.00 per equity share) to the offer price to eligible employees bidding under the employee reservation portion ("Employee Discount"). Price Band: Rs. 988 per equity share of face value of Rs. 2 each. The floor price is 494.00 times of the face value of the equity shares. Bids can be made for a minimum of 15 equity shares of face value of Rs. 2 each and in multiples of 15 equity shares of face value of Rs. 2 each thereafter. Discount of Rs. 90.00 per equity share of face value of Rs. 2 is being offered to eligible employees bidding in the employee reservation portion.
Issue
Opens On Closes On
24-Aug-26 27-Aug-26
Money Payable On
Application Allotment
988.00 0.00
Minimum Application for shares in Nos : 15 Further Multiples of : 15
(.Cr) Lead Managers to the Issue
Project Cost (.Cr) 142.03 Avendus Capital Private Limited
Project Financed through Current Offer (.Cr) 1757.00  
Post Issue Equity Share Capital (.Cr) 12.85
Issue Price () 988.00
Projects
Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by its Company
General Corporate Purpose
Promoted By
Anil Satwani
Kashish Satwani
Sushil Satwani
Listing At
BSE
NSE
Registrar to the Issue
MUFG Intime India Pvt Ltd
Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.